KIU, Main Campus – In October, officials at the Ministry of
Health said Uganda would start its first COVID-19 vaccine clinical trials this
month, November. However, this plan now faces hindrance following a new
requirement for the Uganda Virus Research Institute (UVRI) to submit another
According to Prof Pontiano Kaleebu, the UVRI director, they
were no longer sure of the time when the clinical trial will start, saying that
the requirement to submit a new protocol for the trial was due to changes in
dosage of the vaccine developed by partner, Imperial College London.
"We are modifying the protocol before we can submit to
the committee for approval. So I can't give the timeline when the clinical
trial will start," Prof Kaleebu said.
Apparently, the dosage of a vaccine affects the level of the immunity that a recipient develops after the injection.
The research protocols involving human beings are approved by
the Uganda National Council of Science and Technology and the National Drug
Global participation in clinical trials for vaccines is
viewed by experts as the fastest way to avail a safe and effective COVID-19
remedy for the entire world population. Clinical trial for COVID-19 vaccine in
other countries is still ongoing.